Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:46 pm
| PEG Ratio | 0.91 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gillanders Arbuthnot & Company Ltd operates primarily within the Plantations sector, focusing on tea and coffee production. As of the latest reporting period, the company recorded sales of ₹449 Cr for FY 2023, which represented a slight increase from ₹406 Cr in FY 2022. However, sales figures fluctuated considerably in the quarterly reports, with the highest quarterly sales of ₹143.56 Cr recorded in September 2022, followed by a significant drop to ₹77.42 Cr in March 2023. The most recent quarter, June 2023, saw sales rebound to ₹87.68 Cr. Over the trailing twelve months (TTM), revenue stood at ₹447 Cr, indicating a relatively stable revenue performance despite the volatility. The company’s operating profit margin (OPM) has been under pressure, recorded at -0.14% for the latest fiscal year, reflecting challenges in managing costs amid fluctuating revenues. Overall, while Gillanders Arbuthnot shows resilience in sales, the inconsistency in quarterly performance raises questions about operational stability.
Profitability and Efficiency Metrics
In terms of profitability, Gillanders Arbuthnot’s net profit for FY 2023 was reported at ₹31 Cr, translating to an earnings per share (EPS) of ₹6.94. However, the company’s profitability metrics have shown considerable volatility, with net profit margins fluctuating from 4.02% in FY 2022 to 3.30% in FY 2023, and a rebound to 6.02% in FY 2025. The interest coverage ratio (ICR) stood at 2.93x, indicating a manageable level of debt service relative to earnings. The company’s return on equity (ROE) was recorded at 6.83%, while the return on capital employed (ROCE) stood at 6.80%, both of which are relatively low compared to industry averages. The cash conversion cycle (CCC) was reported at 146 days, reflecting inefficiencies in managing working capital. Overall, while the company has reported positive net profits, the operational efficiency metrics suggest significant room for improvement, particularly in cost management and working capital utilization.
Balance Sheet Strength and Financial Ratios
Gillanders Arbuthnot’s balance sheet reflects a mixed picture of financial health. As of the latest reporting, the company’s total assets were valued at ₹514 Cr, with total liabilities at ₹477 Cr, leading to a debt-to-equity ratio of 0.51x. The company reported reserves of ₹224 Cr and borrowings of ₹139 Cr, indicating a conservative leverage strategy. The price-to-book value (P/BV) ratio stood at 0.83x, suggesting that the stock may be undervalued relative to its net asset value. The working capital days were reported at -7, indicating potential liquidity challenges. Current and quick ratios were 0.96x and 0.45x, respectively, highlighting concerns about short-term liquidity. Gillanders Arbuthnot’s ability to maintain a positive net profit while managing a reasonable level of debt reflects a cautious approach to financial management, although the liquidity ratios warrant close monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillanders Arbuthnot indicates a strong promoter presence, with promoters holding 69.05% of the total equity as of the latest reporting period. This significant stake suggests a solid commitment from the founding shareholders. Foreign institutional investors (FIIs) have not shown interest, holding 0% of the shares, while domestic institutional investors (DIIs) hold a mere 0.31%. The public shareholding stood at 30.60%, with the number of shareholders increasing to 10,447, reflecting growing interest among retail investors. The stability in promoter holding over the reporting periods may instill confidence among existing and potential investors. However, the lack of institutional backing could pose risks, as institutional investors often bring stability and credibility. Overall, the strong promoter backing coupled with an increasing number of shareholders may provide a foundation for potential growth, but the absence of institutional investment remains a concern.
Outlook, Risks, and Final Insight
Looking ahead, Gillanders Arbuthnot faces both opportunities and challenges. Key strengths include a stable sales performance relative to historical figures, a strong promoter stake, and a manageable debt level that provides room for strategic investments. However, risks include the volatility in quarterly sales figures, low profitability margins, and potential liquidity challenges highlighted by the current and quick ratios. The operational efficiency metrics indicate a need for improved working capital management, which could enhance profitability. If the company can effectively address these operational challenges and leverage its strong promoter backing, it may position itself for growth in the competitive tea and coffee sector. Conversely, failure to improve profitability and operational efficiency may hinder its ability to capitalize on market opportunities, impacting investor confidence in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gillanders Arbuthnot & Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 410 Cr. | 190 | 357/162 | 73.5 | 125 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 45.2 Cr. | 30.1 | 45.7/26.0 | 43.0 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 121 Cr. | 134 | 193/126 | 101 | 213 | 1.12 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 5.21 Cr. | 8.23 | 8.23/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 136 Cr. | 438 | 689/0.00 | 14.6 | 455 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 9,654.56 Cr | 409.04 | 123.69 | 243.86 | 0.40% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 124.81 | 143.56 | 103.24 | 77.42 | 87.68 | 105.42 | 101.43 | 68.75 | 84.85 | 126.75 | 127.64 | 103.94 | 88.37 |
| Expenses | 121.76 | 119.46 | 101.82 | 94.04 | 90.30 | 96.42 | 125.76 | 84.41 | 90.11 | 101.46 | 119.87 | 106.03 | 88.49 |
| Operating Profit | 3.05 | 24.10 | 1.42 | -16.62 | -2.62 | 9.00 | -24.33 | -15.66 | -5.26 | 25.29 | 7.77 | -2.09 | -0.12 |
| OPM % | 2.44% | 16.79% | 1.38% | -21.47% | -2.99% | 8.54% | -23.99% | -22.78% | -6.20% | 19.95% | 6.09% | -2.01% | -0.14% |
| Other Income | 12.60 | 3.91 | 6.07 | 7.67 | 4.59 | 1.86 | 8.25 | -1.07 | 1.74 | 3.53 | 13.23 | 3.99 | 0.49 |
| Interest | 5.24 | 4.39 | 3.99 | 4.42 | 3.98 | 3.51 | 3.94 | 2.86 | 3.46 | 2.85 | 2.95 | 3.10 | 3.24 |
| Depreciation | 2.95 | 3.09 | 3.01 | 2.91 | 3.03 | 3.15 | 2.86 | 2.72 | 2.67 | 2.78 | 2.80 | 2.61 | 2.65 |
| Profit before tax | 7.46 | 20.53 | 0.49 | -16.28 | -5.04 | 4.20 | -22.88 | -22.31 | -9.65 | 23.19 | 15.25 | -3.81 | -5.52 |
| Tax % | 8.58% | 11.89% | -51.02% | -33.54% | 4.37% | 13.33% | -2.32% | 10.49% | 1.76% | 7.37% | 14.56% | -153.54% | -1.27% |
| Net Profit | 6.81 | 18.09 | 0.74 | -10.81 | -5.26 | 3.64 | -22.35 | -24.65 | -9.82 | 21.47 | 13.03 | 2.04 | -5.46 |
| EPS in Rs | 3.19 | 8.48 | 0.35 | -5.07 | -2.46 | 1.71 | -10.47 | -11.55 | -4.60 | 10.06 | 6.11 | 0.96 | -2.56 |
Last Updated: August 20, 2025, 10:30 am
Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 88.37 Cr.. The value appears to be declining and may need further review. It has decreased from 103.94 Cr. (Mar 2025) to 88.37 Cr., marking a decrease of 15.57 Cr..
- For Expenses, as of Jun 2025, the value is 88.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.03 Cr. (Mar 2025) to 88.49 Cr., marking a decrease of 17.54 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.09 Cr. (Mar 2025) to -0.12 Cr., marking an increase of 1.97 Cr..
- For OPM %, as of Jun 2025, the value is -0.14%. The value appears strong and on an upward trend. It has increased from -2.01% (Mar 2025) to -0.14%, marking an increase of 1.87%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 3.99 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 3.50 Cr..
- For Interest, as of Jun 2025, the value is 3.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.24 Cr., marking an increase of 0.14 Cr..
- For Depreciation, as of Jun 2025, the value is 2.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.61 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is -5.52 Cr.. The value appears to be declining and may need further review. It has decreased from -3.81 Cr. (Mar 2025) to -5.52 Cr., marking a decrease of 1.71 Cr..
- For Tax %, as of Jun 2025, the value is -1.27%. The value appears to be increasing, which may not be favorable. It has increased from -153.54% (Mar 2025) to -1.27%, marking an increase of 152.27%.
- For Net Profit, as of Jun 2025, the value is -5.46 Cr.. The value appears to be declining and may need further review. It has decreased from 2.04 Cr. (Mar 2025) to -5.46 Cr., marking a decrease of 7.50 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.56. The value appears to be declining and may need further review. It has decreased from 0.96 (Mar 2025) to -2.56, marking a decrease of 3.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:19 am
| Metric | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 355 | 863 | 817 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 | 447 |
| Expenses | 333 | 821 | 812 | 653 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 | 416 |
| Operating Profit | 22 | 42 | 5 | 28 | 50 | 65 | 28 | 31 | 30 | 12 | -34 | 26 | 31 |
| OPM % | 6% | 5% | 1% | 4% | 7% | 9% | 4% | 7% | 7% | 3% | -9% | 6% | 7% |
| Other Income | 11 | 9 | 12 | 30 | 21 | 12 | 26 | 7 | 17 | 30 | 14 | 22 | 21 |
| Interest | 10 | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 | 12 |
| Depreciation | 9 | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 | 11 |
| Profit before tax | 14 | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 | 29 |
| Tax % | 21% | -27% | 4% | 4% | 112% | 95% | 22% | 2% | -42% | -22% | 6% | -7% | |
| Net Profit | 11 | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 31 |
| EPS in Rs | 6.69 | -4.16 | -25.93 | -8.83 | -4.02 | 0.15 | -7.13 | -7.32 | 7.66 | 6.94 | -22.78 | 12.52 | 14.57 |
| Dividend Payout % | 25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -511.11% | 65.45% | 52.63% | 100.00% | -6.67% | 200.00% | -6.25% | -426.67% | 155.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 576.57% | -12.82% | 47.37% | -106.67% | 206.67% | -206.25% | -420.42% | 581.77% |
Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -8% |
| 3 Years: | 3% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 0% |
| TTM: | 139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 34% |
| 3 Years: | 21% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:45 am
Balance Sheet
Last Updated: May 13, 2025, 3:30 pm
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 107 | 266 | 155 | 262 | 271 | 268 | 255 | 231 | 248 | 255 | 196 | 224 |
| Borrowings | 91 | 456 | 480 | 449 | 424 | 392 | 366 | 227 | 183 | 145 | 129 | 139 |
| Other Liabilities | 72 | 242 | 209 | 203 | 225 | 244 | 214 | 145 | 144 | 129 | 130 | 130 |
| Total Liabilities | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
| Fixed Assets | 112 | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 |
| CWIP | 10 | 11 | 4 | 9 | 17 | 14 | 15 | 14 | 12 | 11 | 9 | 13 |
| Investments | 13 | 28 | 28 | 29 | 34 | 29 | 17 | 8 | 3 | 0 | 0 | 0 |
| Other Assets | 145 | 525 | 522 | 457 | 460 | 454 | 404 | 287 | 271 | 241 | 205 | 245 |
| Total Assets | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
- For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 28.00 Cr..
- For Borrowings, as of Mar 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 129.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 130.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 514.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 256.00 Cr.. The value appears to be declining and may need further review. It has decreased from 263.00 Cr. (Mar 2024) to 256.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2024) to 245.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Mar 2025, the value is 514.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
Notably, the Reserves (224.00 Cr.) exceed the Borrowings (139.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.00 | -414.00 | -475.00 | -421.00 | -374.00 | -327.00 | -338.00 | -196.00 | -153.00 | -133.00 | -163.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 56 | 57 | 54 | 53 | 47 | 45 | 54 | 36 | 21 | 29 | 51 |
| Inventory Days | 130 | 135 | 156 | 207 | 253 | 219 | 206 | 240 | 389 | 287 | 314 | 225 |
| Days Payable | 97 | 92 | 112 | 148 | 180 | 166 | 164 | 163 | 220 | 129 | 164 | 130 |
| Cash Conversion Cycle | 59 | 99 | 101 | 113 | 126 | 100 | 87 | 130 | 204 | 179 | 180 | 146 |
| Working Capital Days | 72 | -21 | 1 | -6 | -24 | -25 | -47 | -11 | 2 | -1 | -11 | -7 |
| ROCE % | 10% | -0% | 1% | 6% | 8% | 4% | 4% | 7% | 4% | -8% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Diluted EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Cash EPS (Rs.) | 17.61 | -17.27 | 12.55 | 13.49 | 0.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Revenue From Operations / Share (Rs.) | 207.65 | 170.22 | 210.39 | 190.42 | 201.83 |
| PBDIT / Share (Rs.) | 16.98 | -9.36 | 14.78 | 22.12 | 18.70 |
| PBIT / Share (Rs.) | 11.89 | -14.87 | 9.18 | 16.29 | 11.19 |
| PBT / Share (Rs.) | 11.70 | -21.56 | 5.71 | 5.38 | -7.15 |
| Net Profit / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| NP After MI And SOA / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| PBDIT Margin (%) | 8.17 | -5.50 | 7.02 | 11.61 | 9.26 |
| PBIT Margin (%) | 5.72 | -8.73 | 4.36 | 8.55 | 5.54 |
| PBT Margin (%) | 5.63 | -12.66 | 2.71 | 2.82 | -3.54 |
| Net Profit Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| NP After MI And SOA Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| Return on Networth / Equity (%) | 10.89 | -22.35 | 5.35 | 6.05 | -6.18 |
| Return on Capital Employeed (%) | 8.60 | -12.43 | 6.06 | 9.99 | 6.96 |
| Return On Assets (%) | 5.19 | -10.19 | 2.69 | 2.73 | -2.50 |
| Long Term Debt / Equity (X) | 0.05 | 0.08 | 0.09 | 0.21 | 0.30 |
| Total Debt / Equity (X) | 0.51 | 0.53 | 0.47 | 0.63 | 0.73 |
| Asset Turnover Ratio (%) | 0.89 | 0.70 | 0.78 | 0.64 | 0.56 |
| Current Ratio (X) | 0.96 | 0.85 | 1.01 | 1.03 | 0.99 |
| Quick Ratio (X) | 0.45 | 0.36 | 0.47 | 0.50 | 0.61 |
| Inventory Turnover Ratio (X) | 0.46 | 0.52 | 0.78 | 0.95 | 0.57 |
| Interest Coverage Ratio (X) | 2.93 | -1.40 | 1.75 | 2.03 | 1.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.20 | -2.41 | 1.23 | 1.70 | 0.63 |
| Enterprise Value (Cr.) | 343.60 | 282.86 | 273.58 | 318.10 | 271.78 |
| EV / Net Operating Revenue (X) | 0.77 | 0.77 | 0.60 | 0.78 | 0.63 |
| EV / EBITDA (X) | 9.48 | -14.15 | 8.67 | 6.74 | 6.81 |
| MarketCap / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| Price / BV (X) | 0.83 | 0.71 | 0.47 | 0.51 | 0.36 |
| Price / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| EarningsYield | 0.13 | -0.31 | 0.11 | 0.11 | -0.16 |
After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.61. This value is within the healthy range. It has increased from -17.27 (Mar 24) to 17.61, marking an increase of 34.88.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 207.65. It has increased from 170.22 (Mar 24) to 207.65, marking an increase of 37.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.98. This value is within the healthy range. It has increased from -9.36 (Mar 24) to 16.98, marking an increase of 26.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from -14.87 (Mar 24) to 11.89, marking an increase of 26.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.70. This value is within the healthy range. It has increased from -21.56 (Mar 24) to 11.70, marking an increase of 33.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For PBDIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from -5.50 (Mar 24) to 8.17, marking an increase of 13.67.
- For PBIT Margin (%), as of Mar 25, the value is 5.72. This value is below the healthy minimum of 10. It has increased from -8.73 (Mar 24) to 5.72, marking an increase of 14.45.
- For PBT Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 10. It has increased from -12.66 (Mar 24) to 5.63, marking an increase of 18.29.
- For Net Profit Margin (%), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 8. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.89. This value is below the healthy minimum of 15. It has increased from -22.35 (Mar 24) to 10.89, marking an increase of 33.24.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.60. This value is below the healthy minimum of 10. It has increased from -12.43 (Mar 24) to 8.60, marking an increase of 21.03.
- For Return On Assets (%), as of Mar 25, the value is 5.19. This value is within the healthy range. It has increased from -10.19 (Mar 24) to 5.19, marking an increase of 15.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.05, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.51, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has increased from 0.70 (Mar 24) to 0.89, marking an increase of 0.19.
- For Current Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1.5. It has increased from 0.85 (Mar 24) to 0.96, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 24) to 0.45, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 4. It has decreased from 0.52 (Mar 24) to 0.46, marking a decrease of 0.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 3. It has increased from -1.40 (Mar 24) to 2.93, marking an increase of 4.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 3. It has increased from -2.41 (Mar 24) to 2.20, marking an increase of 4.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 343.60. It has increased from 282.86 (Mar 24) to 343.60, marking an increase of 60.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.48. This value is within the healthy range. It has increased from -14.15 (Mar 24) to 9.48, marking an increase of 23.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. It has increased from -0.31 (Mar 24) to 0.13, marking an increase of 0.44.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
- Net Profit Margin: 6.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.6% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.89% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.2
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.45
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.5 (Industry average Stock P/E: 123.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.51
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | C-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001 | secretarial@gillandersarbuthnot.com http://www.gillandersarbuthnot.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Kumar Kothari | Chairman |
| Mr. Mahesh Sodhani | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Non Executive Director |
| Mr. Arvind Baheti | Independent Director |
| Mr. Charudatta Raghvendra Prayag | Independent Director |
| Mr. Kothaneth Ashok | Independent Director |
FAQ
What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?
Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 03 November 2025) is 80.12 which is 34.33% lower the current market price of 122.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 260 Cr. market cap, FY2025-2026 high/low of 152/90.0, reserves of ₹224 Cr, and liabilities of 514 Cr.
What is the Market Cap of Gillanders Arbuthnot & Company Ltd?
The Market Cap of Gillanders Arbuthnot & Company Ltd is 260 Cr..
What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 03 November 2025?
The current stock price of Gillanders Arbuthnot & Company Ltd as on 03 November 2025 is 122.
What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is 152/90.0.
What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?
The Stock P/E of Gillanders Arbuthnot & Company Ltd is 12.5.
What is the Book Value of Gillanders Arbuthnot & Company Ltd?
The Book Value of Gillanders Arbuthnot & Company Ltd is 115.
What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?
The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.
What is the ROCE of Gillanders Arbuthnot & Company Ltd?
The ROCE of Gillanders Arbuthnot & Company Ltd is 6.80 %.
What is the ROE of Gillanders Arbuthnot & Company Ltd?
The ROE of Gillanders Arbuthnot & Company Ltd is 6.83 %.
What is the Face Value of Gillanders Arbuthnot & Company Ltd?
The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.